Podiatrist, Foot & Ankle Surgery · Miami, FL
NPI
1033172630
Since 2006
Specialty
Podiatrist, Foot & Ankle Surgery
Code 213ES0103X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3095 NW 7th St
Miami, FL, 33125
Phone (305) 642-4044
Groups this clinician bills Medicare through
Medicare paid, 2024
$54K
685 services
Medicare patients, 2024
163
Average age 77
Drug cost, 2024
$74K
4,091 prescriptions
Company payments, 2023
$70.78
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark A Maederer Jr. was code 99213 (office e&m - established), 313 times for 133 patients. In total Mark A Maederer Jr. billed 685 services in 16 codes, and Medicare paid $54K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-08-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 313 | 133 | $73.79 | $23K |
| 10060 Skin | Office | 120 | 67 | $106.47 | $13K |
| 11305 Removal or Shaving of Skin Growth | Office | 115 | 65 | $83.33 | $9,583 |
| 11721 Nail Procedure | Office | 45 | 35 | $36.94 | $1,662 |
| 99214 Office E&M - Established | Office | 25 | 17 | $101.15 | $2,529 |
| 97597 Debridement | Office | 23 | 17 | $82.97 | $1,908 |
By year: 2022 $66K for 788 services; 2023 $66K for 819 services; 2024 $54K for 685 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark A Maederer Jr. prescribed most often to Medicare patients was Ciclopirox (Ciclopirox Olamine), with 1,774 prescriptions and refills. In total Mark A Maederer Jr. wrote 4,091 Medicare prescriptions that cost $74K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ciclopirox Ciclopirox Olamine | 1,774 | 1,991 | 591 | $35K |
| Ammonium Lactate Generic | 1,324 | 1,598 | 453 | $19K |
| Mupirocin Generic | 389 | 408 | 130 | $2,503 |
| Diclofenac Sodium Generic | 201 | 213 | 52 | $3,959 |
| Ciclopirox Generic | 118 | 120 | 35 | $2,424 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 40 | 40 | 29 | $470 |
| Meloxicam Generic | 36 | 44 | 13 | $70.48 |
| Naproxen Generic | 26 | 26 | Under 11 | $191 |
| Betamethasone Dipropionate Generic | 21 | 21 | 14 | $1,114 |
| Azithromycin Generic | 20 | 20 | Under 11 | $50.89 |
| Ibuprofen Generic | 19 | 25 | Under 11 | $237 |
| Doxycycline Hyclate Generic | 17 | 17 | Under 11 | $145 |
| Clotrimazole Generic | 13 | 21 | Under 11 | $179 |
| Lidocaine Generic | 12 | 12 | Under 11 | $44.91 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 11 | 11 | Under 11 | $286 |
Brand drugs: - claims; generic drugs: 4,081 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Mark A Maederer Jr. $70.78 ($70.78 in general payments such as food, travel and fees) from 3 companies. The largest payer was Smith+Nephew, Inc. with $26.82.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.